120 related articles for article (PubMed ID: 32251807)
1. Risk Factors for Early Mortality in Patients with Primary Central Nervous System Lymphoma: A Large-Cohort Retrospective Study.
Zhou X; Niu X; Li J; Zhang S; Yang W; Yang Y; Mao Q; Liu Y
World Neurosurg; 2020 Jun; 138():e905-e912. PubMed ID: 32251807
[TBL] [Abstract][Full Text] [Related]
2. Survival among patients with primary central nervous system lymphoma, 1973-2004.
Norden AD; Drappatz J; Wen PY; Claus EB
J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
[TBL] [Abstract][Full Text] [Related]
3. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
4. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
[TBL] [Abstract][Full Text] [Related]
5. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
6. Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study.
Chi K; Zhou R; Luo Z; Zhao H; Jiang Y; He B; Li Y; Chen D; Feng M; Liang Y; Yang W; Liu R; Yao D; Lin X; Xu X
Front Oncol; 2023; 13():1096027. PubMed ID: 36845683
[TBL] [Abstract][Full Text] [Related]
7. Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995-2016: A population-based SEER analysis.
Chen C; Sun P; Sun XQ; Chen SY; Hang Yang ; Wang Y; Li ZM
Hematol Oncol; 2023 Apr; 41(2):248-256. PubMed ID: 34472655
[TBL] [Abstract][Full Text] [Related]
8. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance.
Raoux D; Duband S; Forest F; Trombert B; Chambonnière ML; Dumollard JM; Khaddage A; Gentil-Perret A; Péoc'h M
Neuropathology; 2010 Jun; 30(3):232-40. PubMed ID: 19925562
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: age and performance status are more important than treatment modality.
Corry J; Smith JG; Wirth A; Quong G; Liew KH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):615-20. PubMed ID: 9635710
[TBL] [Abstract][Full Text] [Related]
11. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.
Hayakawa T; Takakura K; Abe H; Yoshimoto T; Tanaka R; Sugita K; Kikuchi H; Uozumi T; Hori T; Fukui H
J Neurooncol; 1994; 19(3):197-215. PubMed ID: 7807171
[TBL] [Abstract][Full Text] [Related]
14. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma.
Kaulen LD; Galluzzo D; Hui P; Barbiero F; Karschnia P; Huttner A; Fulbright R; Baehring JM
J Neurooncol; 2019 Aug; 144(1):107-115. PubMed ID: 31190317
[TBL] [Abstract][Full Text] [Related]
16. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.
Dandachi D; Ostrom QT; Chong I; Serpa JA; Giordano TP; Kruchko C; Barnholtz-Sloan JS; Fowler N; Colen RR; Morón FE
Cancer Causes Control; 2019 May; 30(5):477-488. PubMed ID: 30888569
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
Uldrick TS; Pipkin S; Scheer S; Hessol NA
AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
[TBL] [Abstract][Full Text] [Related]
19. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
Wang H; Wang M; Wei J; Wang L; Mao L; Jin J
J Int Med Res; 2018 Feb; 46(2):883-894. PubMed ID: 28984175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
